There is extensive literature describing adiponectin as an adipokine that is associated with insulin sensitivity and vascular wall anti-inflammatory activity in type 2 diabetes, and showing that lower levels of adiponectin are associated with insulin resistance in type 2 diabetes [34–38]. Here, ADIPOQ is linked to type 2 diabetes mellitus.